BASILEA PHARMACEUTICALS
LIVE

Serial Number

97540286

Owner

Basilea Pharmaceutica AG

Attorney

Evan A. Raynes

Filing Date

Aug 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA PHARMACEUTICALS Trademark

Serial Number: 97540286

BASILEA PHARMACEUTICALS is a trademark filed by Basilea Pharmaceutica AG on August 8, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Basilea Pharmaceutica AG (44 trademarks)

Grenzacherstrasse 487
CH-4005 Basel , CH

Entity Type: 99

Trademark Details

Filing Date

August 8, 2022

Registration Date

Not Registered

Published for Opposition

June 27, 2023

Goods & Services

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

SOU TEAS EXTENSION RECEIVED
Feb 16, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2025 EXRA
SOU EXTENSION 4 GRANTED
Aug 18, 2025 EX4G
SOU EXTENSION 4 FILED
Aug 18, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 13, 2025 EX3G
SOU EXTENSION 3 FILED
Feb 13, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024 EXRA
SOU EXTENSION 2 GRANTED
Aug 14, 2024 EX2G
SOU EXTENSION 2 FILED
Aug 14, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 16, 2024 EX1G
SOU EXTENSION 1 FILED
Feb 16, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 22, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 24, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 24, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 24, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 24, 2023 CNEA
ASSIGNED TO EXAMINER
May 24, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2022 NWOS
NEW APPLICATION ENTERED
Aug 11, 2022 NWAP